申请人:Slade Rachel
公开号:US20100184975A1
公开(公告)日:2010-07-22
The invention provides novel compounds useful for the treatment of neurodegenerative disorders including Alzheimer's disease and dementia. The compounds have a substituents chosen from -L-C(═O)OH, -L-CH═CHC(═O)OH, -L-C(═O)NH
2
, -L-C(═0)NH(C
1-3
alkyl), -L-C(═O)N(C
1-3
alkyl)
2
, -L-S(═O)
2
(C
1-3
alkyl), -L-S(═O)
2
NH
2
, -L-S(═O)
2
N(C
1-3
alkyl)
2
, -L-S(═O)
2
NH(C
1-3
alkyl), -L-C(═O)NHOH, -L-C(═O)CH
2
NH
2
, -L-C(═O)CH
2
OH, -L-C(═O)CH
2
SH, -L-C(═O)NHCN, -L-NHC(═O)OR
o
, -L-C(═O)NHR
o
, -L-NH(C═O)NHR
o
, -L-C(═O)N(R
o
)
2
, -L-NH(C═O)N(R
o
)
2
, -L-sulfo, -L-(2,6 difluorophenol), -L-phosphono, and -L-tetrazolyl, where L is a linker.
该发明提供了新型化合物,可用于治疗神经退行性疾病,包括阿尔茨海默病和痴呆症。这些化合物具有以下取代基:-L-C(═O)OH,-L-CH═CHC(═O)OH,-L-C(═O)NH2,-L-C(═0)NH(C1-3烷基),-L-C(═O)N(C1-3烷基)2,-L-S(═O)2(C1-3烷基),-L-S(═O)2NH2,-L-S(═O)2N(C1-3烷基)2,-L-S(═O)2NH(C1-3烷基),-L-C(═O)NHOH,-L-C(═O)CH2NH2,-L-C(═O)CH2OH,-L-C(═O)CH2SH,-L-C(═O)NHCN,-L-NHC(═O)ORo,-L-C(═O)NHRo,-L-NH(C═O)NHRo,-L-C(═O)N(Ro)2,-L-NH(C═O)N(Ro)2,-L-
磺酸基,-L-(
2,6-二氟苯酚),-L-
磷酸基和-L-
四唑基,其中L是连接基。